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www.jacctctabstracts2014com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: Our 3-y FU data reinforce the concept that TAVI should be avoided when
the native annulus perimeter is> 8,5 cm. In this context the larger CoreValve available
(31 mm) cannot be use as oversizing prosthesis. To the contrary when an oversizing
valve prostheis can be used acceptable results are achieved. In this setting of pts TAVI
showed no death, and good clinical outcomes that were sustained at 3-y FU.
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Background: The incidence and prognostic impact of late bleeding complications
(LBC) after TAVR are unknown. We sought to identify the incidence, predictors, and
prognostic impact of LBC (30 days) after TAVR.
Methods: Clinical and echocardiographic outcomes of patients who underwent
TAVR within the randomized cohorts and continued access registries in the PART-
NER trial were analyzed after stratifying by the occurrence of LBC. Predictors of LBC
and its association with 30-day to 1-year mortality were assessed.
Results: Among 2,401 patients who underwent TAVR and survived to 30 days, LBC
occurred in 142 (5.9%) at median time of 132 [71, 230] days after the index procedure.
Gastrointestinal (n¼58; 40.8%), neurologic (n¼22; 15.5%), and traumatic falls
(n¼11; 7.8%) were identiﬁed as the most frequent types of LBC. Independent pre-
dictors of major LBC were the presence of atrial ﬁbrillation or ﬂutter (AF) at baseline
or 30 days, the presence of moderate/severe paravalvular leak (PVL) at 30 days, the
presence of low hemoglobin at baseline, and greater left ventricular mass at 30 days.
LBC was identiﬁed as a strong independent predictor of mortality between 30 days
and 1 year (adjusted HR 3.91, 95% CI [2.67, 5.71], p< 0.001). The presence of AF,
especially when LBCs occurred, was associated with a poor prognosis and high rate of
mortality.
Conclusions: LBC after TAVR were frequent and associated with increased mor-
tality. A better-individualized and risk-adjusted antithrombotic therapy after TAVR is
urgently needed in this high-risk population.TCT-757
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Background: Transcatheter aortic valve implantation is the contemporary treatment
of choice for high/prohibitive surgical risk patients with severe aortic stenosis.
Methods: Outcomes of consecutive 275 (61% female) severe aortic stenosis patients,
treated with TAVI and followed up to 3 years (mean 702 days), were analyzed and
reported according to the Valve Academic Research Consortium 2 deﬁnitions. The
primary end point was death from any cause.
Results: This patient group (60% women) was characterized by advanced age (mean
81.76.8), high mean log-EuroScore ¼ 19.112 and STS score ¼ 8.15.
The Medtronic-CoreValve device was utilized in 195(71%) and the Edwards-
Sapien device in 80(29%) of patients. The trans-femoral, trans-axillar, trans-apical,JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Vatrans-aortic and retroperitoneal route were used in 224, 20, 29, 1 and 1 patients;
respectively. Procedural success was 97.1%. One month, 1 year, 2 and 3 years survival
rates were 97%, 91%, 85% and 70%; respectively. Peri-procedural\in-hospital stroke
was diagnosed in 9 (3.2%) patients. Permanent pacemaker was required in 40 (14.5%)
patients: (36 cases in CoreValve and 4 in Sapien valves). Signiﬁcant paravalvular leak
(moderate) was noted in 22 (8%) patients. After the procedure, mean valve gradients
decreased from 51.216 to 8.17 (p< 0.001). Symptomatic improvement was
evident during follow up, having 98% of patients in NYHA-FC I or II.Conclusions: The current report signiﬁes that catheter-based treatment of mostly
elderly patients with severe aortic stenosis is feasible, safe and associated with
satisfactory long-term outcomes.
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Background: Acute kidney injury (AKI) is a serious complication after transcatheter
aortic valve implantation (TAVI) and patients with preexisting renal impairment seem
to be especially prone to AKI. Very few data exist about the impact of invasive
hemodynamics on the occurrence of AKI after TAVI. The objectives oft the study
were (i) to determine the incidence and predictive factors for AKI with emphasis on
invasive hemodynamics, and (ii) to examine short-and longterm outcome of these
patients.
Methods: A total of 540 patients (mean age: 80.27.1, logES: 24.517.9%) un-
dergoing TAVI were included in the study. Patients were divided into three groups
according to their glomerular ﬁltration rate (GFR) before TAVI (A: normal renal
function i.e. GFR  60ml/min; B: impaired renal function i.e. GFR 30-59 ml/min; C:
severe impaired renal function i.e. GFR < 30 ml/min). Renal function and survival
were recorded over 12 months.
Results: Overall 30-day mortality was 10.2 % and 12-month mortality was 21.5%.
Subgroup analysis showed signiﬁcant differences between the groups with regard to
30-day-mortality (A: 5.4%, B: 9.0%, C: 25.0%) and 12-month mortality (A: 15.0%, B:
32.0%, C: 49%). AKI occurred in 30 patients (5.6%), of which the majority were
patients of group B (16 patients). 30-day-mortality of patients with AKI was 53.3%
(16 patients) and 12-month-mortality was 73.3% (22 patients). Systemic arterial
pressures were signiﬁcantly higher before and after TAVI in patients without AKI
compared to patients with AKI, whereas preprocedural and postprocedural pulmonary
and right atrial pressures did not differ between both groups. Predictive factors forlvular disease - Aortic: TAVR B221
